Artelo Biosciences (ARTL) Market Capitalization (2019 - 2025)

Artelo Biosciences (ARTL) has reported Market Capitalization for 7 consecutive years, with $72921.8 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Market Capitalization fell 80.82% year-over-year to $72921.8 in Q4 2025; TTM through Dec 2025 was $72921.8, a 80.82% decrease from a year earlier, with the FY2025 full-year figure at $72047.1, down 80.82% from the prior year.
• Market Capitalization was $72921.8 for Q4 2025 at Artelo Biosciences, down from $274353.5 in the prior quarter.
• Over five years, Market Capitalization peaked at $2.1 billion in Q4 2021 and troughed at $72921.8 in Q4 2025.
• A 5-year average of $107.5 million and a median of $683790.1 in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization soared 305592.28% in 2021 and sank 80.82% in 2025, its largest moves.
• Over 5 years, Market Capitalization stood at $2.1 billion in 2021, then slumped by 99.96% to $917008.6 in 2022, then tumbled by 45.9% to $496062.0 in 2023, then retreated by 23.37% to $380149.9 in 2024, then slumped by 80.82% to $72921.8 in 2025.
• The last three Market Capitalization figures came in at $72921.8 (Q4 2025), $274353.5 (Q3 2025), and $793174.5 (Q2 2025), per Business Quant data.